Research Compound Thymalin is a laboratory material for analytical and in vitro work, with a total declared content of 10 mg.
What is Thymalin?
Thymalin originally denotes a complex of polypeptides isolated from the thymus, not a single defined molecule. For this reason it is particularly important with this material to check the declared composition and the analytical documentation of the specific batch.
Research background
The preparation was developed in the 1970s by Vladimir Khavinson and Vyacheslav Morozov in Leningrad, as part of research into peptide bioregulators from various tissues. The same research school later developed synthetic short peptides such as Epithalon.
Mechanism and scientific context
The literature describes effects on T-lymphocyte differentiation and on the ratio of lymphocyte subpopulations in experimental models, as well as research in the context of age-related thymic involution. Because it is a mixture of peptides, attributing an effect to any single molecule is methodologically difficult.
Main research areas
- thymus biology and thymic involution
- T-lymphocyte differentiation
- peptide complexes and their standardisation
- immune signalling
Level of evidence
Limited and heterogeneous, largely from regional literature and the same research school.
Related
For other thymus-related peptides see Thymosin Alpha-1.
Research use only: for laboratory, analytical and in vitro research only; not for use in humans or animals. Guidance on batch documentation is available in our COA guide.